×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
24755 views
La SFCO vous propose un cycle de formation sur le cancer de l’ovaire en 3 Webinars.
 
On vous propose avec des sessions de 90 minutes, de faire le point sur :
  • deux techniques chirurgicales en vidéo
  • l’importance de la recherche de la mutation BRCA en particulier l’impact thérapeutique a l’ère des inhibiteurs de PARP
  • la préhabilitation et la réhabilitation précoce
  • un point d’actualité sur une publication récente
Nous vous donnons RDV pour le premier Webinar en direct de Nantes le vendredi 14 Décembre à 12h30 !

Programme

12:30 Introduction
 
12:35
Charlotte Bourgin – Cécile Loaec 
 
12:50
Carlos Martínez Gómez
 
13:05
Cancer de l’ovaire et BRCA : Comprendre le mécanisme des mutations BRCA et leur impact clinique
Thibaut de la Motte Rouge
 
13:20
Préhabiliation avant chirurgie abdominale majeure
Florence Boiffard
 
13:35
Point d’actu : LION
Fabrice Lecuru
 
13:50 Conclusion

 

Audience

  •  Chirurgiens oncologiques et oncologues francophones
Shooting date : 2018-12-14
Last update : 2021-07-08

Cancer de l’ovaire : Cycle de formation en 3 Webinars

La SFCO vous propose un cycle de formation sur le cancer de l’ovaire en 3 Webinars.   On vous propose avec des sessions de 90 minutes, de faire le point sur : deux techni...

Share
5 comments
Join the Discussion
See previous comments (1)
  • juan jose T. Excellente video Carlos !

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • nassir H. excellent session

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Franck R.

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        • Bourgin T. Bravo charlotte

            Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
            Your browser doesn't have Flash, Silverlight or HTML5 support.


          • sarhane H. Bonjour,depuis peu de temps , je n'arrive pas à lire les vidéos pourtant je suis inscrit!
            Merci de bien vouloir m'aider à résoudre ce problème.
            Cordialement

              Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
              Your browser doesn't have Flash, Silverlight or HTML5 support.


            Suggestions

            Monday, October 4th 2021 from 06pm to 07:30pm (GMT+1)
            Honolulu : Monday, October 4th 2021 from 07am to 08:30am (GMT-10)
            San Francisco : Monday, October 4th 2021 from 10am to 11:30am (GMT-7)
            New York : Monday, October 4th 2021 from 01pm to 02:30pm (GMT-4)
            Buenos Aires : Monday, October 4th 2021 from 02pm to 03:30pm (GMT-3)
            Reykjavik : Monday, October 4th 2021 from 05pm to 06:30pm (GMT)
            London / Dublin : Monday, October 4th 2021 from 06pm to 07:30pm (GMT+1)
            Paris / Berlin : Monday, October 4th 2021 from 07pm to 08:30pm (GMT+2)
            Istanbul : Monday, October 4th 2021 from 08pm to 09:30pm (GMT+3)
            Moscou / Dubaï : Monday, October 4th 2021 from 09pm to 10:30pm (GMT+4)
            Bangkok : Tuesday, October 5th 2021 from 12am to 01:30am (GMT+7)
            Shanghai : Tuesday, October 5th 2021 from 01am to 02:30am (GMT+8)
            Tokyo : Tuesday, October 5th 2021 from 02am to 03:30am (GMT+9)
            Sydney : Tuesday, October 5th 2021 from 04am to 05:30am (GMT+11)
            Wellington : Tuesday, October 5th 2021 from 06am to 07:30am (GMT+13)

            Cancer de l'ovaire : observance long terme sous inhibiteurs de PARP

            Episode 1

            Share
            Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
            Honolulu : Tuesday, December 13th 2022 from 07am to 08:30am (GMT-10)
            San Francisco : Tuesday, December 13th 2022 from 09am to 10:30am (GMT-8)
            New York : Tuesday, December 13th 2022 from 12pm to 01:30pm (GMT-5)
            Buenos Aires : Tuesday, December 13th 2022 from 02pm to 03:30pm (GMT-3)
            London / Dublin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT)
            Paris / Berlin : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
            Istanbul : Tuesday, December 13th 2022 from 07pm to 08:30pm (GMT+2)
            Moscou / Dubaï : Tuesday, December 13th 2022 from 09pm to 10:30pm (GMT+4)
            Bangkok : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+7)
            Shanghai : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+8)
            Tokyo : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+9)
            Sydney : Wednesday, December 14th 2022 from 03am to 04:30am (GMT+10)
            Wellington : Wednesday, December 14th 2022 from 05am to 06:30am (GMT+12)

            Last improvements in advanced ovarian cancer treatment

            Trials that have or will impact practices in the management of patients with advanced ovarian cancer

            Share
            Scroll Up